(-)-epigallocatechin 3-gallate decreases expression ISO RGD:737503 6480464 epigallocatechin gallate results in decreased expression of SRD5A2 mRNA CTD PMID:20706672 1,2-dimethylhydrazine decreases expression ISO RGD:737504 6480464 1, 2-Dimethylhydrazine results in decreased expression of SRD5A2 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO RGD:737503 6480464 Estradiol results in decreased expression of SRD5A2 mRNA CTD PMID:20106945 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:737504 6480464 hydroxyflutamide inhibits the reaction [Dihydrotestosterone results in increased expression of SRD5A2 mRNA] CTD PMID:15056816 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of SRD5A2 mRNA CTD PMID:22131296 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:737504 6480464 Dihydrotestosterone results in increased expression of SRD5A2 mRNA CTD PMID:15056816 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:19464308 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SRD5A2 mRNA CTD PMID:11222880 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737504 6480464 Tetrachlorodibenzodioxin results in decreased expression of SRD5A2 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737504 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SRD5A2 gene] CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SRD5A2 mRNA CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737503 6480464 Tetrachlorodibenzodioxin affects the expression of SRD5A2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SRD5A2 mRNA CTD PMID:22298810 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 3,17-Androstanediol glucuronide decreases abundance ISO RGD:737503 6480464 SRD5A2 gene SNP results in decreased abundance of androstane-3, 17-diol glucuronide CTD PMID:17136762 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 [3 more ... CTD PMID:19464308 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of SRD5A2 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol decreases methylation ISO RGD:737504 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of SRD5A2 exon CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:737504 6480464 Fenretinide results in increased expression of SRD5A2 mRNA CTD PMID:28973697 aflatoxin B1 affects expression ISO RGD:737503 6480464 Aflatoxin B1 affects the expression of SRD5A2 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:737503 6480464 Aflatoxin B1 results in decreased expression of SRD5A2 mRNA CTD PMID:22100608 aflatoxin B1 decreases expression ISO RGD:737504 6480464 Aflatoxin B1 results in decreased expression of SRD5A2 mRNA CTD PMID:19770486 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SRD5A2 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:737503 6480464 Antirheumatic Agents results in decreased expression of SRD5A2 mRNA CTD PMID:24449571 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of SRD5A2 mRNA CTD PMID:16938428 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SRD5A2 gene CTD PMID:33854195 benzo[a]pyrene affects methylation ISO RGD:737503 6480464 Benzo(a)pyrene affects the methylation of SRD5A2 exon, Benzo(a)pyrene affects the methylation of SRD5A2 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:737503 6480464 Benzo(a)pyrene results in decreased expression of SRD5A2 mRNA CTD PMID:32234424 bifenthrin decreases expression ISO RGD:737504 6480464 bifenthrin results in decreased expression of SRD5A2 mRNA CTD PMID:26071804 bisphenol A decreases expression ISO RGD:737504 6480464 bisphenol A results in decreased expression of SRD5A2 mRNA, bisphenol A results in decreased expression of SRD5A2 protein CTD PMID:25434310 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SRD5A2 mRNA CTD PMID:30816183 , PMID:32528016 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SRD5A2 mRNA, bisphenol A results in decreased expression of SRD5A2 protein CTD PMID:23405234 more ... C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of SRD5A2 mRNA CTD PMID:19167457 cadmium atom increases expression ISO RGD:737503 6480464 Cadmium results in increased expression of SRD5A2 mRNA CTD PMID:21120746 chlorogenic acid decreases expression ISO RGD:737503 6480464 Chlorogenic Acid results in decreased expression of SRD5A2 mRNA CTD PMID:20706672 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SRD5A2 gene CTD PMID:33854195 clothianidin increases expression ISO RGD:737503 6480464 clothianidin results in increased expression of SRD5A2 mRNA CTD PMID:31626844 cyclosporin A decreases expression ISO RGD:737503 6480464 Cyclosporine results in decreased expression of SRD5A2 mRNA CTD PMID:20106945 cypermethrin increases expression ISO RGD:737504 6480464 cypermethrin results in increased expression of SRD5A2 mRNA CTD PMID:21142847 D-aspartic acid increases expression EXP 6480464 D-Aspartic Acid results in increased expression of SRD5A2 mRNA CTD PMID:26044185 DDE decreases activity ISO RGD:737503 6480464 Dichlorodiphenyl Dichloroethylene results in decreased activity of SRD5A2 protein CTD PMID:17218080 dextran sulfate multiple interactions ISO RGD:737504 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SRD5A2 mRNA CTD PMID:29950665 dibutyl phthalate decreases expression ISO RGD:737504 6480464 Dibutyl Phthalate results in decreased expression of SRD5A2 mRNA, Dibutyl Phthalate results in decreased expression of SRD5A2 protein CTD PMID:25434310 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of SRD5A2 mRNA CTD PMID:26948521 , PMID:27079746 dutasteride decreases expression ISO RGD:737503 6480464 Dutasteride results in decreased expression of SRD5A2 mRNA CTD PMID:16806904 fenarimol decreases activity ISO RGD:737503 6480464 fenarimol results in decreased activity of SRD5A2 protein CTD PMID:17218080 finasteride decreases activity ISO RGD:737503 6480464 Finasteride results in decreased activity of SRD5A2 protein CTD PMID:17218080 more ... finasteride multiple interactions ISO RGD:737503 6480464 Finasteride inhibits the reaction [Testosterone results in increased expression of SRD5A2 mRNA] more ... CTD PMID:23523586 fluoroethene decreases activity ISO RGD:737503 6480464 vinyl fluoride analog results in decreased activity of SRD5A2 protein CTD PMID:8689240 flutamide decreases activity ISO RGD:737503 6480464 Flutamide results in decreased activity of SRD5A2 protein CTD PMID:17218080 furan increases expression EXP 6480464 furan results in increased expression of SRD5A2 mRNA CTD PMID:22079235 genistein decreases expression ISO RGD:737503 6480464 Genistein results in decreased expression of SRD5A2 mRNA CTD PMID:20706672 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SRD5A2 gene CTD PMID:33854195 hydroxyflutamide multiple interactions ISO RGD:737504 6480464 hydroxyflutamide inhibits the reaction [Dihydrotestosterone results in increased expression of SRD5A2 mRNA] CTD PMID:15056816 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SRD5A2 gene CTD PMID:33854195 lidocaine decreases expression EXP 6480464 Lidocaine results in decreased expression of SRD5A2 mRNA CTD PMID:35283115 linuron decreases activity ISO RGD:737503 6480464 Linuron results in decreased activity of SRD5A2 protein CTD PMID:17218080 mangiferin decreases activity ISO RGD:737503 6480464 mangiferin results in decreased activity of SRD5A2 protein CTD PMID:20823678 methyltestosterone decreases activity ISO RGD:737503 6480464 Methyltestosterone results in decreased activity of SRD5A2 protein CTD PMID:17218080 metoclopramide increases expression EXP 6480464 Metoclopramide results in increased expression of SRD5A2 mRNA CTD PMID:18978642 N-Nitrosopyrrolidine decreases expression ISO RGD:737503 6480464 N-Nitrosopyrrolidine results in decreased expression of SRD5A2 mRNA CTD PMID:32234424 O-methyleugenol decreases expression ISO RGD:737503 6480464 methyleugenol results in decreased expression of SRD5A2 mRNA CTD PMID:32234424 Osajin decreases expression ISO RGD:737503 6480464 osajin results in decreased expression of SRD5A2 mRNA CTD PMID:20706672 paracetamol increases expression ISO RGD:737504 6480464 Acetaminophen results in increased expression of SRD5A2 mRNA CTD PMID:29246445 paracetamol multiple interactions ISO RGD:737504 6480464 PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of SRD5A2 mRNA] CTD PMID:29246445 PCB138 multiple interactions EXP 6480464 [3 more ... CTD PMID:19464308 perfluorooctanoic acid multiple interactions ISO RGD:737504 6480464 [perfluorooctanoic acid co-treated with Dietary Fats more ... CTD PMID:20118188 , PMID:23626681 perfluorooctanoic acid decreases expression ISO RGD:737504 6480464 perfluorooctanoic acid results in decreased expression of SRD5A2 mRNA CTD PMID:20118188 , PMID:23626681 piperidine decreases activity ISO RGD:737503 6480464 piperidine analog results in decreased activity of SRD5A2 protein CTD PMID:10896124 piperidine decreases activity EXP 6480464 piperidine analog results in decreased activity of SRD5A2 protein CTD PMID:10896124 pirinixic acid multiple interactions ISO RGD:737504 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SRD5A2 mRNA CTD PMID:19710929 Pomiferin decreases expression ISO RGD:737503 6480464 pomiferin results in decreased expression of SRD5A2 mRNA CTD PMID:20706672 pravastatin decreases expression ISO RGD:737504 6480464 Pravastatin results in decreased expression of SRD5A2 mRNA CTD PMID:27225895 prochloraz decreases activity ISO RGD:737503 6480464 prochloraz results in decreased activity of SRD5A2 protein CTD PMID:17218080 progesterone decreases activity ISO RGD:737503 6480464 Progesterone analog results in decreased activity of SRD5A2 protein CTD PMID:20359488 puerarin decreases expression ISO RGD:737503 6480464 puerarin results in decreased expression of SRD5A2 mRNA CTD PMID:20706672 resveratrol decreases expression ISO RGD:737503 6480464 resveratrol results in decreased expression of SRD5A2 mRNA CTD PMID:20706672 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Testosterone results in increased expression of SRD5A2 mRNA] CTD PMID:25714330 Rosavin decreases expression ISO RGD:737503 6480464 rosavin results in decreased expression of SRD5A2 mRNA CTD PMID:20706672 sulpiride increases expression EXP 6480464 Sulpiride results in increased expression of SRD5A2 mRNA CTD PMID:18978642 testosterone multiple interactions ISO RGD:737503 6480464 Finasteride inhibits the reaction [Testosterone results in increased expression of SRD5A2 mRNA] more ... CTD PMID:23523586 testosterone increases expression EXP 6480464 Testosterone results in increased expression of SRD5A2 mRNA CTD PMID:22131296 more ... testosterone multiple interactions EXP 6480464 resveratrol inhibits the reaction [Testosterone results in increased expression of SRD5A2 mRNA] CTD PMID:25714330 testosterone increases expression ISO RGD:737503 6480464 Testosterone results in increased expression of SRD5A2 mRNA CTD PMID:23523586 tetrachloroethene decreases expression ISO RGD:737504 6480464 Tetrachloroethylene results in decreased expression of SRD5A2 mRNA CTD PMID:28973375 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SRD5A2 gene CTD PMID:33854195 titanium dioxide multiple interactions ISO RGD:737504 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of SRD5A2 mRNA CTD PMID:29950665 tributylstannane decreases activity ISO RGD:737503 6480464 tributyltin results in decreased activity of SRD5A2 protein CTD PMID:12231121 tributylstannane multiple interactions ISO RGD:737503 6480464 Finasteride promotes the reaction [tributyltin inhibits the reaction [Testosterone results in increased expression of SRD5A2 mRNA]] more ... CTD PMID:23523586 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of SRD5A2 mRNA CTD PMID:21683754 Tributyltin oxide decreases activity ISO RGD:737503 6480464 bis(tri-n-butyltin)oxide results in decreased activity of SRD5A2 protein CTD PMID:17218080 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of SRD5A2 mRNA CTD PMID:33387578 triphenylstannane decreases activity ISO RGD:737503 6480464 triphenyltin results in decreased activity of SRD5A2 protein CTD PMID:17218080 zaragozic acid A decreases expression ISO RGD:737504 6480464 squalestatin 1 results in decreased expression of SRD5A2 mRNA CTD PMID:27225895 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of SRD5A2 mRNA CTD PMID:27225895 zoledronic acid increases expression ISO RGD:737503 6480464 zoledronic acid results in increased expression of SRD5A2 mRNA CTD PMID:24714768